Serum Institute of India
The world's largest vaccine maker by doses, which developed CERVAVAC, India's first home-made HPV vaccine, so that cervical cancer prevention no longer depends on imported shots.
Overview
The Serum Institute of India was founded in 1966 in Pune and makes more vaccine doses than any other company. With support from the Department of Biotechnology it developed CERVAVAC, a quadrivalent HPV vaccine against types 6, 11, 16 and 18 produced in Hansenula polymorpha yeast, indicated for girls and women aged 9 to 26 (cervical, vulvar, vaginal and anal cancer and genital warts) and boys and men aged 9 to 26 (anal cancer and genital warts), given as two doses at 0 and 6 months for ages 9 to 14 and three doses for ages 15 to 26. CERVAVAC received Indian market authorisation in 2022 and was introduced in 2023; published comparisons report immunogenicity non-inferior to established vaccines, and it is the intended supply for India's planned national HPV vaccination programme.
Scorecard
All companies- approved products +12
- modalities +2
- regions +8
- registry trials +10
India's first home-made HPV vaccine, protecting against the two virus types that cause most cervical cancers and the two that cause genital warts, at a price meant for a national programme.
A vaccine against nine HPV types that prevents about 90% of cervical cancers, and now works with a single dose.
Pages like this
not linked directly; found by shared links- IdeaSingle-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries
Shares CERVAVAC (quadrivalent HPV vaccine, India), Nonavalent HPV vaccine, HPV & HBV vaccination, Prevention we already have is not deployed.
- IdeaEliminate infection-caused cancers: HPV, hepatitis B and C, H. pylori and EBV
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.
- IdeaSwitch every country to single-dose HPV vaccination and add catch-up to age 26
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.
- PersonJian Zhou
Shares Nonavalent HPV vaccine, HPV & HBV vaccination, Prevention we already have is not deployed, Cervical cancer.
- IdeaHPV self-testing with same-day treatment as the national cervical programme
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.
- TrialKEN SHE (single-dose HPV vaccine)
Shares Nonavalent HPV vaccine, HPV & HBV vaccination, Prevention we already have is not deployed, Cervical cancer.
- IdeaCommunity-tailored HPV vaccine confidence campaigns with school-based delivery
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Cervical cancer, Head and neck squamous cell carcinoma.
- TrialIARC India HPV vaccine dose study (one, two or three doses)
Shares CERVAVAC (quadrivalent HPV vaccine, India), Nonavalent HPV vaccine, HPV & HBV vaccination, Prevention we already have is not deployed.